We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.
- Authors
Henry, David H; Costa, Luis; Goldwasser, Francois; Hirsh, Vera; Hungria, Vania; Prausova, Jana; Scagliotti, Giorgio Vittorio; Sleeboom, Harm; Spencer, Andrew; Vadhan-Raj, Saroj; von Moos, Roger; Willenbacher, Wolfgang; Woll, Penella J; Wang, Jianming; Jiang, Qi; Jun, Susie; Dansey, Roger; Yeh, Howard
- Abstract
This study compared denosumab, a fully human monoclonal anti-receptor activator of nuclear factor kappa-B ligand antibody, with zoledronic acid (ZA) for delaying or preventing skeletal-related events (SRE) in patients with advanced cancer and bone metastases (excluding breast and prostate) or myeloma.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Vol 29, Issue 9, p1125
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2010.31.3304